Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujun Chen

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Cancer Cell|February 13, 2026
Chemotherapy triggers immune evasion by fostering LEPR<sup>+</sup> Kupffer cell differentiation in liver metastasesXuege Wang, Qiang Pan, Yaqi Li, et al.
Nature Genetics|September 2, 2020
Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancerShuai Gao, Sujun Chen, Dong Han, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2014
Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemiaYumi Yashiro-Ohtani, Hongfang Wang, Chongzhi Zang, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerBeatriz German, Katherine L Morel, Teia Noel, et al.
Nature Communications|September 17, 2020
Haploinsufficiency of RREB1 causes a Noonan-like RASopathy via epigenetic reprogramming of RAS-MAPK pathway genesOliver A Kent, Manipa Saha, Etienne Coyaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to ImmunotherapyShihong Peng, Pan Hu, Yu-Tian Xiao, et al.
Cell|July 24, 2018
Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19Junjie Tony Hua, Musaddeque Ahmed, Haiyang Guo, et al.
Nature Communications|October 30, 2022
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumorsSujun Chen, Jessica Petricca, Wenbin Ye, et al.
Cancer Cell|July 21, 2023
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancerXiaoling Li, Yunguan Wang, Su Deng, et al.
Cancer Cell|April 18, 2025
Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiationMona Teng, Jiacheng Guo, Xin Xu, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Cancer Cell|February 13, 2026
Chemotherapy triggers immune evasion by fostering LEPR<sup>+</sup> Kupffer cell differentiation in liver metastasesXuege Wang, Qiang Pan, Yaqi Li, et al.
Nature Genetics|September 2, 2020
Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancerShuai Gao, Sujun Chen, Dong Han, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2014
Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemiaYumi Yashiro-Ohtani, Hongfang Wang, Chongzhi Zang, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerBeatriz German, Katherine L Morel, Teia Noel, et al.
Nature Communications|September 17, 2020
Haploinsufficiency of RREB1 causes a Noonan-like RASopathy via epigenetic reprogramming of RAS-MAPK pathway genesOliver A Kent, Manipa Saha, Etienne Coyaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to ImmunotherapyShihong Peng, Pan Hu, Yu-Tian Xiao, et al.
Cell|July 24, 2018
Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19Junjie Tony Hua, Musaddeque Ahmed, Haiyang Guo, et al.
Nature Communications|October 30, 2022
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumorsSujun Chen, Jessica Petricca, Wenbin Ye, et al.
Cancer Cell|July 21, 2023
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancerXiaoling Li, Yunguan Wang, Su Deng, et al.
Cancer Cell|April 18, 2025
Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiationMona Teng, Jiacheng Guo, Xin Xu, et al.
Pageof 6